Tradestie Institutional Equity Comparison Engine

VIVS vs SLS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

SLS Overall Edge

SLS Captures Institutional Edge (3โ€“0 Pillars ยท 5โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to SELLAS Life Sciences Group, Inc. Common Stock (SLS) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, VIVS trades at N/M Forward P/E with -10117.0% operating margin (-51.4% YoY revenue) versus SLS at N/M Forward P/E and 0.0% operating margin (-82.5% YoY). In options structure, VIVS sits in BREAKDOWN (N/A IV; Dealer Gamma Walls on Pro) against SLS sits in CONSOLIDATION (16th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
VIVS N/M vs SLS N/M Fwd P/E
Growth & Margin Winner SLS
Op Margin -10117.0% vs 0.0% ยท YoY -51.4% vs -82.5%
Momentum & Technical Winner SLS
1Y -87.0% vs +834.6% ยท 52W Pos 5% vs 57%
Options & Structure Winner SLS
BREAKDOWN (N/A IV) vs CONSOLIDATION (16th %ile IV)
VIVS NASDAQ
VivoSim Labs, Inc. Common Stock
Biological Products, (No Disgnostic Substances)
$0.29
+142.92% 1D
Market Cap $2.4M
1M Return +64.69%
1Y Return -86.99%
Forward P/E N/M
Unified AI Score
36.8 / 100 SELL
Tech 5.0 Fund 38.0 Flow 50.0 Mom 50.0
SLS NASDAQ
SELLAS Life Sciences Group, Inc. Common Stock
Pharmaceutical Preparations
$14.86
-17.21% 1D
Market Cap $3.7B
1M Return +22.41%
1Y Return +834.59%
Forward P/E N/M
Unified AI Score
39.3 / 100 SELL
Tech 50.0 Fund 37.0 Flow 68.0 Mom 48.9

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: VIVS -86.99% SLS +834.59% Spread: +921.58 pp (SLS Lead)

Pillar 3 Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant Revenue ($B) & Operating Margin (%)
Period VIVS Revenue SLS Revenue VIVS Op. Margin SLS Op. Margin Margin Edge
FY2019 $0M N/A -882.4% N/A VIVS
FY2020 $0M $0M -977.9% -893.8% SLS
FY2021 N/A $10M N/A -332.8% SLS
FY2022 $0M $0M -765.3% -4195.0% VIVS
FY2023 $0M N/A -4792.2% N/A VIVS
FY2024 $0M N/A -13840.4% N/A VIVS
FY2025 $0M N/A -8761.1% N/A VIVS
FY2026 $0M N/A -8768.7% N/A VIVS

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: VIVS (2) vs SLS (5)
Institutional Metric VIVS SLS Criterion Row Winner
Market Capitalization Scale $2.4M $3.7B Larger Scale SLS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth -51.4% -82.5% Higher Growth VIVS
Operating Margin (TTM) Profitability -10117.0% 0.0% Higher Margin SLS
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency -343.1% -40.3% Higher ROE SLS
52-Week Range Position Momentum 5% ($0โ€“$3) 57% ($1โ€“$25) Stronger Trend SLS
Beta / 30D Volatility Risk Regime 0.83ฮฒ ยท 480% Vol 1.84ฮฒ ยท 551% Vol Lower Realized Risk VIVS
Unified Institutional Score Composite Signal 36.8 / 100 (SELL) 39.3 / 100 (SELL) Higher Composite SLS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full VIVS vs SLS Buy Guide
VIVS BREAKDOWN
73d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live VIVS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
SLS CONSOLIDATION
101d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 16th %ile
IV Regime Compressed (<25th %ile)
Live SLS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither VIVS nor SLS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.